# Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain Infarctions

> **NCT05685069** · — · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 230 (estimated)

## Conditions studied

- Silent Stroke
- Silent Cerebral Infarct
- Covert Brain Infarct
- Covert Brain Infarction
- Lacune
- Silent Brain Infarction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05685069
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2024-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05685069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05685069, "Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain Infarctions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05685069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*